Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.22−0.70 (-2.51%)
Close on Nov 17, 2026Market cap $1.57BP/E –Yield –
Enovis EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Enovis's EPS for the twelve months ending Jul 3, 2026 was -$19.26. For fiscal 2025 it was -$20.75. The highest annual figure on record is $9.06 in fiscal 2014.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.75 | – |
| FY2024 | Dec 31, 2024 | -$14.93 | – |
| FY2023 | Dec 31, 2023 | -$0.61 | – |
| FY2022 | Dec 31, 2022 | -$0.25 | -117.9% |
| FY2021 | Dec 31, 2021 | $1.40 | +50.5% |
| FY2020 | Dec 31, 2020 | $0.93 | – |
| FY2019 | Dec 31, 2019 | -$11.67 | -435.3% |
| FY2018 | Dec 31, 2018 | $3.48 | -4.9% |
| FY2017 | Dec 31, 2017 | $3.66 | +17.3% |
| FY2016 | Dec 31, 2016 | $3.12 | -22.4% |
| FY2015 | Dec 31, 2015 | $4.02 | -55.6% |
| FY2014 | Dec 31, 2014 | $9.06 | +96.1% |
| FY2013 | Dec 31, 2013 | $4.62 | – |
| FY2012 | Dec 31, 2012 | -$2.76 | -1020.0% |
| FY2011 | Dec 31, 2011 | $0.30 | -73.0% |
| FY2010 | Dec 31, 2010 | $1.11 | -32.7% |
| FY2009 | Dec 31, 2009 | $1.65 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | -$0.02 | – |
| Q1 FY2026 | Apr 3, 2026 | -$0.15 | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.10 | – |
| Q3 FY2025 | Oct 3, 2025 | -$9.99 | – |
| Q2 FY2025 | Jul 4, 2025 | -$0.64 | – |
| Q1 FY2025 | Apr 4, 2025 | -$0.98 | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.58 | -25260.0% |
| Q3 FY2024 | Sep 27, 2024 | -$0.58 | – |
| Q2 FY2024 | Jun 28, 2024 | -$0.34 | – |
| Q1 FY2024 | Mar 29, 2024 | -$1.32 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.05 | – |
| Q3 FY2023 | Sep 29, 2023 | -$0.05 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.18 | -112.8% |
| Q1 FY2023 | Mar 31, 2023 | -$0.43 | -253.6% |
| Q4 FY2022 | Dec 31, 2022 | -$0.71 | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.23 | -351.0% |
| Q2 FY2022 | Jul 1, 2022 | $1.41 | +151.8% |
| Q1 FY2022 | Apr 1, 2022 | $0.28 | -30.0% |
| Q4 FY2021 | Dec 31, 2021 | -$0.04 | -105.6% |
| Q3 FY2021 | Oct 1, 2021 | $0.49 | +63.3% |
| Q2 FY2021 | Jul 2, 2021 | $0.56 | – |
| Q1 FY2021 | Apr 2, 2021 | $0.40 | +344.4% |
| Q4 FY2020 | Dec 31, 2020 | $0.72 | – |
| Q3 FY2020 | Oct 2, 2020 | $0.30 | +25.0% |
| Q2 FY2020 | Jul 3, 2020 | -$0.18 | – |
| Q1 FY2020 | Apr 3, 2020 | $0.09 | – |
| Q4 FY2019 | Dec 31, 2019 | -$0.36 | -130.8% |
| Q3 FY2019 | Sep 27, 2019 | $0.24 | -69.2% |
| Q2 FY2019 | Jun 28, 2019 | -$10.35 | -1212.9% |
| Q1 FY2019 | Mar 29, 2019 | -$1.17 | -295.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.17 | +254.5% |
| Q3 FY2018 | Sep 28, 2018 | $0.78 | -29.7% |
| Q2 FY2018 | Jun 29, 2018 | $0.93 | -27.9% |
| Q1 FY2018 | Mar 31, 2018 | $0.60 | -35.5% |
| Q4 FY2017 | Dec 31, 2017 | $0.33 | -64.5% |
| Q3 FY2017 | Sep 29, 2017 | $1.11 | +60.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.29 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.93 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.93 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.69 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?